If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSBI.L Regulatory News (SBI)

  • There is currently no data for SBI

Holding(s) in Company

28 Oct 2021 13:56

RNS Number : 6181Q
SourceBio International PLC
28 October 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BKSB1674

Issuer Name

SOURCEBIO INTERNATIONAL PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Harwood Capital Management (Gibraltar) Limited

City of registered office (if applicable)

Gibraltar

Country of registered office (if applicable)

Gibraltar

Name

City of registered office

Country of registered office

Harwood Capital LLP

London

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Harwood Capital LLP

London

United Kingdom

North Atlantic Smaller Companies Investment Trust Plc

London

United Kingdom

Oryx International Growth Fund Limited

St Peter Port

Guersey

5. Date on which the threshold was crossed or reached

20-Oct-2021

6. Date on which Issuer notified

27-Oct-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

27.33

0.00

27.33

20,275,680

Position of previous notification (if applicable)

29.14

0.00

29.14

21,616,421

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

B00BKSB1674

2500000

3.370000

B00BKSB1674

9453161

12.740000

B00BKSB1674

8322519

11.220000

Sub Total 8.A

20275680

27.330000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Christopher Harwood Bernard Mills

Oryx International Growth Fund Limited

3.370000

Christopher Harwood Bernard Mills

North Atlantic Smaller Companies Investment Trust plc

12.740000

Christopher Harwood Bernard Mills

Harwood Capital LLP

11.220000

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

27-Oct-2021

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAAEPALNFFFA
12
Date   Source Headline
30th Dec 20227:00 amRNSCancellation - SourceBio International Plc
20th Dec 202212:38 pmRNSResults of General Meeting and Tender Offer
23rd Nov 20227:00 amRNSProposed Cancellation and Tender Offer
11th Nov 20225:27 pmRNSHolding(s) in Company
10th Nov 202211:55 amRNSHolding(s) in Company
9th Nov 20227:00 amRNSTrading Update and Proposed Cancellation
1st Nov 202212:04 pmRNSHolding(s) in Company
18th Oct 202212:17 pmRNSHolding(s) in Company
14th Oct 20225:25 pmRNSHolding(s) in Company
21st Sep 20227:00 amRNSUpdate on VAT dispute with HMRC
8th Sep 20227:00 amRNSHalf-year Report
19th Aug 20227:00 amRNSNotice of Results
2nd Aug 20227:00 amRNSFirst Half Trading Update
15th Jun 20221:23 pmRNSResult of AGM
15th Jun 20227:00 amRNSAGM Statement
11th May 20224:11 pmRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSAnnual Report Posting and Notice of AGM
26th Apr 202211:33 amRNSHolding(s) in Company
7th Apr 20227:00 amRNSDirector's Share Purchase
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
5th Apr 20227:00 amRNSFinal Results
4th Apr 20223:58 pmRNSDirector/PDMR Shareholding
31st Mar 20223:33 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSNotice of Results
9th Mar 20222:30 pmRNSMedical supply support for the people of Ukraine
8th Mar 20227:00 amRNSAcquisition of LDPath Limited and Trading update
2nd Mar 202212:28 pmRNSDirector/PDMR Shareholding
14th Feb 20224:16 pmRNSDirector/PDMR Shareholding
10th Feb 20224:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20225:11 pmRNSDirector/PDMR Shareholding
3rd Feb 20225:07 pmRNSDirector/PDMR Shareholding
2nd Feb 20227:00 amRNSDirector/PDMR Shareholding
26th Jan 202212:40 pmRNSDirector/PDMR Shareholding
18th Jan 20227:00 amRNSTrading update
17th Jan 20226:13 pmRNSDirector/PDMR Shareholding
23rd Dec 20212:39 pmRNSDirector/PDMR Shareholding
21st Dec 20215:22 pmRNSDirector/PDMR Shareholding
21st Dec 202111:49 amRNSDirector/PDMR Shareholding
16th Dec 20215:06 pmRNSDirector/PDMR Shareholding
14th Dec 20214:44 pmRNSHolding(s) in Company
13th Dec 20214:34 pmRNSDirector/PDMR Shareholding
7th Dec 202112:37 pmRNSDirector/PDMR Shareholding
3rd Dec 20212:02 pmRNSDirector/PDMR Shareholding
1st Dec 20212:29 pmRNSDirector/PDMR Shareholding
26th Nov 202112:10 pmRNSDirector/PDMR Shareholding
19th Nov 20215:42 pmRNSDirector/PDMR Shareholding
17th Nov 20214:29 pmRNSHolding(s) in Company
17th Nov 20214:28 pmRNSDirector/PDMR Shareholding
12th Nov 20215:23 pmRNSDirector/PDMR Shareholding
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.